Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32213 | Streptomyces scsio 1934 | Species | Streptomycetaceae | Bacteria | StreptomeDB* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | ED50 | > | 0.0005 | nM | 2995666 |
NPT1049 | Organism | Measles virus | Measles virus | ED50 | > | 0.0005 | nM | 2995666 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | ED50 | = | 5.00E-06 | nM | 2995666 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | ED50 | = | 5.00E-06 | nM | 2995666 |
NPT137 | Cell Line | L1210 | Mus musculus | ID50 | = | 2.60E-08 | nM | 2995666 |
NPT168 | Cell Line | P388 | Mus musculus | ID50 | = | 3.20E-08 | nM | 2995666 |
NPT1171 | Cell Line | HEp-2 | Homo sapiens | IC50 | = | 30 | nM | 1732556 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 70 | nM | 1732556 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | IC50 | = | 3 | nM | 1732556 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 7320 | nM | 7707320 |
NPT1316 | Individual Protein | Adenosine A2a receptor | Rattus norvegicus | Ki | = | 20400 | nM | 7707320 |
NPT1760 | Individual Protein | Adenosine A3 receptor | Rattus norvegicus | Ki | = | 207000 | nM | 7707320 |
NPT3560 | Individual Protein | Deoxycytidine kinase | Homo sapiens | Ratio | = | 0.0077 | /s/microM | 18570408 |
NPT3560 | Individual Protein | Deoxycytidine kinase | Homo sapiens | Ratio | = | 0.0726 | /s/microM | 18570408 |
NPT2 | Others | Unspecified | Ratio | = | 0.0178 | /s/microM | 18570408 | |
NPT2 | Others | Unspecified | Ratio | = | 0.038 | /s/microM | 18570408 | |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 100000 | nM | 17526755 |
NPT3893 | Organism | Streptococcus sp. | Streptococcus sp. | MIC | = | 100000 | nM | 17526755 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 100000 | nM | 17526755 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Inhibition | = | 44.77 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Inhibition | = | 9.54 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 0.44 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 0.85 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 1.9 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 46.2 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 61.5 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 24.9 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 7.6 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 13 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 73.2 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 48 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 41.3 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 30.8 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 61.6 | % | 19929004 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 32.1 | % | 19929004 |
NPT2 | Others | Unspecified | Ki | > | 100000 | nM | 19731917 | |
NPT2 | Others | Unspecified | Inhibition | = | 9 | % | 19731917 | |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 707.9 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 50.1 | nM | PubChem BioAssay data set |
NPT1197 | Individual Protein | Huntingtin | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 6309.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 20596.2 | nM | PubChem BioAssay data set | |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | = | 4800 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | = | 2958 | nM | PubChem BioAssay data set | |
NPT2944 | Individual Protein | Relaxin receptor 1 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT2944 | Individual Protein | Relaxin receptor 1 | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | AC50 | = | 240.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 13 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8199.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 5060 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 18400 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 7690 | nM | 21711054 |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 170 | nM | 21711054 |
NPT1960 | Cell Line | BV-173 | Homo sapiens | IC50 | = | 0.8 | nM | 21711054 |
NPT2 | Others | Unspecified | IC50 | = | 352 | nM | 21711054 | |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 393 | nM | 21711054 |
NPT4590 | Cell Line | EL4 | Mus musculus | IC50 | = | 848 | nM | 21711054 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 2350 | nM | 21711054 |
NPT457 | Cell Line | BT-549 | Homo sapiens | IC50 | = | 123 | nM | 21711054 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT2380 | Cell Line | SK-N-AS | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT2 | Others | Unspecified | IC50 | > | 10000 | nM | 21711054 | |
NPT76 | Cell Line | C6 | Rattus norvegicus | IC50 | = | 9070 | nM | 21711054 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 9440 | nM | 21711054 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 9430 | nM | 21711054 |
NPT3723 | Cell Line | CT26 | Mus musculus | IC50 | = | 131 | nM | 21711054 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 8280 | nM | 21711054 |
NPT858 | Cell Line | LNCaP | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT2 | Others | Unspecified | IC50 | = | 165 | nM | 21711054 | |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT5888 | Cell Line | HPAC | Homo sapiens | IC50 | = | 9320 | nM | 21711054 |
NPT2 | Others | Unspecified | IC50 | = | 285 | nM | 21711054 | |
NPT1160 | Cell Line | BJ | Homo sapiens | IC50 | > | 10000 | nM | 21711054 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | IC50 | = | 0.5 | nM | 21840722 |
NPT80 | Cell Line | Raji | Homo sapiens | IC50 | = | 9 | nM | 21840722 |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | = | 317.7 | nM | PubChem BioAssay data set | |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 660 | nM | PubChem BioAssay data set |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 316.2 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT586 | Organism | Giardia | Giardia | Potency | 163.2 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 3625 | nM | DrugMatrix in vitro pharmacology data | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 1158.2 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 21.7 | nM | PubChem BioAssay data set | |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | 501.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 679.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3548.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7621.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27041.2 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 651.3 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 959.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 50870 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 206 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 183.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8.2 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 366.3 | nM | PubChem BioAssay data set | |
NPT1663 | Individual Protein | Tyrosine-protein kinase YES | Homo sapiens | Potency | 79258.6 | nM | PubChem BioAssay data set | |
NPT161 | Individual Protein | Rap guanine nucleotide exchange factor 4 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 486.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17782.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 9070 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1778.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30419.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4324 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3434.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 341.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 841.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7079.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 22387.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 135.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 421.6 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 125.9 | nM | PubChem BioAssay data set | |
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 172.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 48.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 298.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4466.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12218.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9520.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26832.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 16.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9439.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21.1 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 5804.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 865 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 30611.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 5308 | nM | PubChem BioAssay data set | ||
NPT396 | Cell Line | T47D | Homo sapiens | IC50 | = | 700 | nM | 25462277 |
NPT2 | Others | Unspecified | IC50 | = | 300 | nM | 25462277 | |
NPT2 | Others | Unspecified | IC50 | = | 1800 | nM | 25462277 | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Activity | = | 15.9 | % | 25618019 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Activity | = | 10 | % | 25618019 |
NPT2 | Others | Unspecified | AC50 | 14130 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 4466.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 28183.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48086.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3863.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1076.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9594.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4821.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 2300 | nM | 25960323 | |
NPT2 | Others | Unspecified | IC50 | = | 200 | nM | 25960323 | |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 10000 | nM | 25960323 |
NPT2 | Others | Unspecified | IC50 | = | 6000 | nM | 25960323 | |
NPT2 | Others | Unspecified | IC50 | = | 4000 | nM | 25960323 | |
NPT2 | Others | Unspecified | IC50 | = | 1000 | nM | 25960323 | |
NPT133 | Cell Line | ZR-75-1 | Homo sapiens | IC50 | > | 100000 | nM | 25960323 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 45000 | nM | 25960323 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC314152 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9846 | High Similarity | NPC161659 |
0.9846 | High Similarity | NPC209525 |
0.9701 | High Similarity | NPC269827 |
0.9552 | High Similarity | NPC156461 |
0.9552 | High Similarity | NPC107374 |
0.9552 | High Similarity | NPC21448 |
0.9549 | High Similarity | NPC229974 |
0.9481 | High Similarity | NPC189068 |
0.9481 | High Similarity | NPC164665 |
0.9412 | High Similarity | NPC219313 |
0.9412 | High Similarity | NPC309832 |
0.9398 | High Similarity | NPC317821 |
0.9343 | High Similarity | NPC121222 |
0.9155 | High Similarity | NPC224076 |
0.9143 | High Similarity | NPC161224 |
0.9143 | High Similarity | NPC211025 |
0.9143 | High Similarity | NPC85689 |
0.9143 | High Similarity | NPC185991 |
0.9078 | High Similarity | NPC321814 |
0.9078 | High Similarity | NPC472816 |
0.9014 | High Similarity | NPC302778 |
0.9014 | High Similarity | NPC164952 |
0.9014 | High Similarity | NPC130586 |
0.9014 | High Similarity | NPC212551 |
0.8951 | High Similarity | NPC174802 |
0.8897 | High Similarity | NPC129756 |
0.8865 | High Similarity | NPC136349 |
0.8828 | High Similarity | NPC316618 |
0.8828 | High Similarity | NPC239737 |
0.8828 | High Similarity | NPC226245 |
0.8824 | High Similarity | NPC33996 |
0.8811 | High Similarity | NPC207633 |
0.8681 | High Similarity | NPC328479 |
0.8671 | High Similarity | NPC150853 |
0.863 | High Similarity | NPC52238 |
0.8571 | High Similarity | NPC313754 |
0.8571 | High Similarity | NPC54320 |
0.8571 | High Similarity | NPC311197 |
0.8533 | High Similarity | NPC323091 |
0.8406 | Intermediate Similarity | NPC320818 |
0.8389 | Intermediate Similarity | NPC195140 |
0.8312 | Intermediate Similarity | NPC326082 |
0.82 | Intermediate Similarity | NPC93365 |
0.8182 | Intermediate Similarity | NPC261595 |
0.8129 | Intermediate Similarity | NPC324033 |
0.8129 | Intermediate Similarity | NPC321458 |
0.8117 | Intermediate Similarity | NPC324484 |
0.8101 | Intermediate Similarity | NPC326529 |
0.8077 | Intermediate Similarity | NPC290959 |
0.8065 | Intermediate Similarity | NPC325906 |
0.805 | Intermediate Similarity | NPC324198 |
0.805 | Intermediate Similarity | NPC189261 |
0.805 | Intermediate Similarity | NPC319100 |
0.7943 | Intermediate Similarity | NPC262926 |
0.7887 | Intermediate Similarity | NPC61198 |
0.7697 | Intermediate Similarity | NPC321052 |
0.7676 | Intermediate Similarity | NPC324009 |
0.7655 | Intermediate Similarity | NPC30326 |
0.7654 | Intermediate Similarity | NPC313897 |
0.7622 | Intermediate Similarity | NPC319221 |
0.7619 | Intermediate Similarity | NPC186619 |
0.7584 | Intermediate Similarity | NPC89147 |
0.7584 | Intermediate Similarity | NPC274384 |
0.7517 | Intermediate Similarity | NPC318590 |
0.7517 | Intermediate Similarity | NPC251233 |
0.7517 | Intermediate Similarity | NPC211820 |
0.7467 | Intermediate Similarity | NPC317746 |
0.7467 | Intermediate Similarity | NPC177169 |
0.745 | Intermediate Similarity | NPC74306 |
0.745 | Intermediate Similarity | NPC315642 |
0.744 | Intermediate Similarity | NPC24589 |
0.7417 | Intermediate Similarity | NPC232408 |
0.7417 | Intermediate Similarity | NPC64705 |
0.7412 | Intermediate Similarity | NPC282458 |
0.7412 | Intermediate Similarity | NPC78941 |
0.7338 | Intermediate Similarity | NPC326694 |
0.7209 | Intermediate Similarity | NPC313514 |
0.7178 | Intermediate Similarity | NPC33382 |
0.7134 | Intermediate Similarity | NPC168702 |
0.7134 | Intermediate Similarity | NPC125659 |
0.7121 | Intermediate Similarity | NPC476564 |
0.7075 | Intermediate Similarity | NPC57279 |
0.7055 | Intermediate Similarity | NPC246193 |
0.7048 | Intermediate Similarity | NPC222174 |
0.7023 | Intermediate Similarity | NPC174114 |
0.7023 | Intermediate Similarity | NPC87981 |
0.6994 | Remote Similarity | NPC14590 |
0.695 | Remote Similarity | NPC327579 |
0.6939 | Remote Similarity | NPC104011 |
0.6933 | Remote Similarity | NPC321393 |
0.6923 | Remote Similarity | NPC276373 |
0.6885 | Remote Similarity | NPC5802 |
0.6861 | Remote Similarity | NPC4837 |
0.6861 | Remote Similarity | NPC312187 |
0.6848 | Remote Similarity | NPC157821 |
0.6712 | Remote Similarity | NPC248007 |
0.6618 | Remote Similarity | NPC18335 |
0.6531 | Remote Similarity | NPC250178 |
0.6524 | Remote Similarity | NPC472834 |
0.6507 | Remote Similarity | NPC139776 |
0.649 | Remote Similarity | NPC287876 |
0.6424 | Remote Similarity | NPC14330 |
0.6402 | Remote Similarity | NPC103388 |
0.6345 | Remote Similarity | NPC68938 |
0.6305 | Remote Similarity | NPC107160 |
0.6214 | Remote Similarity | NPC21461 |
0.6214 | Remote Similarity | NPC160666 |
0.6211 | Remote Similarity | NPC217656 |
0.62 | Remote Similarity | NPC109322 |
0.6173 | Remote Similarity | NPC89139 |
0.6164 | Remote Similarity | NPC296437 |
0.6125 | Remote Similarity | NPC470266 |
0.6124 | Remote Similarity | NPC158055 |
0.6122 | Remote Similarity | NPC189314 |
0.6115 | Remote Similarity | NPC476561 |
0.6061 | Remote Similarity | NPC244700 |
0.6049 | Remote Similarity | NPC476433 |
0.6049 | Remote Similarity | NPC476528 |
0.6034 | Remote Similarity | NPC164845 |
0.6027 | Remote Similarity | NPC313547 |
0.6026 | Remote Similarity | NPC5707 |
0.6012 | Remote Similarity | NPC474986 |
0.6012 | Remote Similarity | NPC476522 |
0.6012 | Remote Similarity | NPC476013 |
0.6012 | Remote Similarity | NPC476520 |
0.6 | Remote Similarity | NPC472833 |
0.6 | Remote Similarity | NPC476408 |
0.5978 | Remote Similarity | NPC265111 |
0.5976 | Remote Similarity | NPC476521 |
0.5934 | Remote Similarity | NPC473585 |
0.5915 | Remote Similarity | NPC476099 |
0.5896 | Remote Similarity | NPC472832 |
0.5896 | Remote Similarity | NPC18308 |
0.5844 | Remote Similarity | NPC180493 |
0.5804 | Remote Similarity | NPC476562 |
0.5769 | Remote Similarity | NPC180462 |
0.5764 | Remote Similarity | NPC119133 |
0.5743 | Remote Similarity | NPC256849 |
0.5741 | Remote Similarity | NPC470141 |
0.5714 | Remote Similarity | NPC47936 |
0.5689 | Remote Similarity | NPC174020 |
0.5671 | Remote Similarity | NPC210947 |
0.5638 | Remote Similarity | NPC303899 |
0.5634 | Remote Similarity | NPC293163 |
0.5625 | Remote Similarity | NPC59314 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC314152 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD185 | Approved |
0.9848 | High Similarity | NPD166 | Approved |
0.9701 | High Similarity | NPD186 | Discovery |
0.9552 | High Similarity | NPD249 | Approved |
0.9552 | High Similarity | NPD250 | Approved |
0.9545 | High Similarity | NPD193 | Suspended |
0.9412 | High Similarity | NPD195 | Approved |
0.9155 | High Similarity | NPD169 | Phase 2 |
0.9143 | High Similarity | NPD283 | Approved |
0.9014 | High Similarity | NPD338 | Approved |
0.9014 | High Similarity | NPD1750 | Clinical (unspecified phase) |
0.9014 | High Similarity | NPD3107 | Discontinued |
0.9014 | High Similarity | NPD1369 | Phase 2 |
0.9014 | High Similarity | NPD242 | Approved |
0.8951 | High Similarity | NPD339 | Approved |
0.8865 | High Similarity | NPD548 | Clinical (unspecified phase) |
0.8828 | High Similarity | NPD2624 | Phase 2 |
0.8828 | High Similarity | NPD2646 | Discontinued |
0.8828 | High Similarity | NPD1732 | Phase 3 |
0.8722 | High Similarity | NPD248 | Discontinued |
0.8667 | High Similarity | NPD7988 | Suspended |
0.8621 | High Similarity | NPD213 | Clinical (unspecified phase) |
0.8621 | High Similarity | NPD214 | Approved |
0.8571 | High Similarity | NPD217 | Approved |
0.8571 | High Similarity | NPD220 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD218 | Approved |
0.8571 | High Similarity | NPD216 | Approved |
0.8571 | High Similarity | NPD219 | Phase 3 |
0.8433 | Intermediate Similarity | NPD870 | Clinical (unspecified phase) |
0.8366 | Intermediate Similarity | NPD2647 | Phase 3 |
0.8228 | Intermediate Similarity | NPD1412 | Clinical (unspecified phase) |
0.82 | Intermediate Similarity | NPD546 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.8101 | Intermediate Similarity | NPD5666 | Phase 2 |
0.8065 | Intermediate Similarity | NPD1776 | Approved |
0.8065 | Intermediate Similarity | NPD1777 | Approved |
0.805 | Intermediate Similarity | NPD4171 | Clinical (unspecified phase) |
0.8043 | Intermediate Similarity | NPD9632 | Phase 3 |
0.7901 | Intermediate Similarity | NPD4716 | Approved |
0.7887 | Intermediate Similarity | NPD252 | Clinical (unspecified phase) |
0.7871 | Intermediate Similarity | NPD3083 | Approved |
0.7853 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.7817 | Intermediate Similarity | NPD194 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD516 | Clinical (unspecified phase) |
0.7784 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.7784 | Intermediate Similarity | NPD2632 | Approved |
0.7784 | Intermediate Similarity | NPD2630 | Approved |
0.7758 | Intermediate Similarity | NPD1692 | Approved |
0.7671 | Intermediate Similarity | NPD549 | Approved |
0.7665 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.7665 | Intermediate Similarity | NPD5682 | Phase 3 |
0.7665 | Intermediate Similarity | NPD5683 | Clinical (unspecified phase) |
0.7665 | Intermediate Similarity | NPD5684 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD9633 | Phase 3 |
0.75 | Intermediate Similarity | NPD9408 | Phase 3 |
0.7468 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7467 | Intermediate Similarity | NPD7158 | Phase 1 |
0.7451 | Intermediate Similarity | NPD3708 | Phase 2 |
0.745 | Intermediate Similarity | NPD582 | Approved |
0.7244 | Intermediate Similarity | NPD231 | Clinical (unspecified phase) |
0.7226 | Intermediate Similarity | NPD3085 | Phase 1 |
0.7209 | Intermediate Similarity | NPD7138 | Phase 2 |
0.7179 | Intermediate Similarity | NPD3086 | Phase 3 |
0.7125 | Intermediate Similarity | NPD4074 | Clinical (unspecified phase) |
0.7065 | Intermediate Similarity | NPD2824 | Phase 2 |
0.7029 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD171 | Discontinued |
0.7 | Intermediate Similarity | NPD9606 | Approved |
0.6995 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6974 | Remote Similarity | NPD3695 | Approved |
0.6974 | Remote Similarity | NPD3696 | Approved |
0.6957 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6957 | Remote Similarity | NPD2876 | Phase 3 |
0.695 | Remote Similarity | NPD9607 | Approved |
0.6918 | Remote Similarity | NPD9605 | Phase 3 |
0.6915 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6915 | Remote Similarity | NPD2902 | Phase 2 |
0.6913 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6867 | Remote Similarity | NPD1119 | Phase 2 |
0.6802 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6786 | Remote Similarity | NPD9374 | Approved |
0.6763 | Remote Similarity | NPD9373 | Approved |
0.6752 | Remote Similarity | NPD1730 | Discontinued |
0.6747 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
0.6733 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.672 | Remote Similarity | NPD4495 | Phase 1 |
0.6713 | Remote Similarity | NPD307 | Approved |
0.6712 | Remote Similarity | NPD9084 | Phase 2 |
0.6689 | Remote Similarity | NPD1058 | Discontinued |
0.6624 | Remote Similarity | NPD4240 | Approved |
0.6623 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6618 | Remote Similarity | NPD8836 | Approved |
0.6603 | Remote Similarity | NPD2253 | Discontinued |
0.6573 | Remote Similarity | NPD1063 | Phase 2 |
0.6562 | Remote Similarity | NPD775 | Approved |
0.6556 | Remote Similarity | NPD282 | Approved |
0.6543 | Remote Similarity | NPD353 | Discontinued |
0.6536 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.6516 | Remote Similarity | NPD799 | Phase 1 |
0.649 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.6471 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.6434 | Remote Similarity | NPD9584 | Phase 2 |
0.6433 | Remote Similarity | NPD1118 | Discontinued |
0.6409 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.6409 | Remote Similarity | NPD207 | Discontinued |
0.6398 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6392 | Remote Similarity | NPD1430 | Approved |
0.6392 | Remote Similarity | NPD1431 | Approved |
0.6383 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6383 | Remote Similarity | NPD4458 | Phase 2 |
0.6345 | Remote Similarity | NPD5080 | Phase 2 |
0.6333 | Remote Similarity | NPD281 | Approved |
0.6294 | Remote Similarity | NPD5079 | Phase 2 |
0.6286 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD1127 | Approved |
0.625 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD1128 | Approved |
0.6224 | Remote Similarity | NPD9375 | Discontinued |
0.6216 | Remote Similarity | NPD9409 | Discontinued |
0.62 | Remote Similarity | NPD798 | Discontinued |
0.6139 | Remote Similarity | NPD6112 | Approved |
0.6124 | Remote Similarity | NPD6840 | Approved |
0.6122 | Remote Similarity | NPD8831 | Approved |
0.6122 | Remote Similarity | NPD8833 | Approved |
0.6105 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6101 | Remote Similarity | NPD1808 | Phase 1 |
0.6096 | Remote Similarity | NPD757 | Phase 3 |
0.6094 | Remote Similarity | NPD5486 | Discontinued |
0.6078 | Remote Similarity | NPD515 | Phase 1 |
0.6076 | Remote Similarity | NPD535 | Approved |
0.6076 | Remote Similarity | NPD1121 | Approved |
0.6076 | Remote Similarity | NPD1120 | Approved |
0.6048 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6028 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6026 | Remote Similarity | NPD8830 | Phase 3 |
0.6014 | Remote Similarity | NPD9417 | Phase 3 |
0.6014 | Remote Similarity | NPD9416 | Phase 3 |
0.6 | Remote Similarity | NPD691 | Discontinued |
0.6 | Remote Similarity | NPD5458 | Discontinued |
0.5974 | Remote Similarity | NPD1085 | Approved |
0.5974 | Remote Similarity | NPD1775 | Approved |
0.5973 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.596 | Remote Similarity | NPD2221 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD9551 | Approved |
0.5938 | Remote Similarity | NPD9550 | Approved |
0.5915 | Remote Similarity | NPD9704 | Approved |
0.5906 | Remote Similarity | NPD1368 | Approved |
0.5888 | Remote Similarity | NPD796 | Phase 2 |
0.5867 | Remote Similarity | NPD9360 | Approved |
0.5867 | Remote Similarity | NPD578 | Discontinued |
0.586 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.5845 | Remote Similarity | NPD8250 | Phase 2 |
0.5844 | Remote Similarity | NPD9544 | Approved |
0.5844 | Remote Similarity | NPD78 | Approved |
0.5833 | Remote Similarity | NPD1354 | Approved |
0.5833 | Remote Similarity | NPD1356 | Approved |
0.5833 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.5828 | Remote Similarity | NPD580 | Discontinued |
0.5814 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5772 | Remote Similarity | NPD9406 | Approved |
0.5769 | Remote Similarity | NPD9366 | Approved |
0.5765 | Remote Similarity | NPD7842 | Phase 2 |
0.5764 | Remote Similarity | NPD9291 | Approved |
0.5746 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.5743 | Remote Similarity | NPD9359 | Approved |
0.5743 | Remote Similarity | NPD9358 | Approved |
0.5742 | Remote Similarity | NPD579 | Clinical (unspecified phase) |
0.5728 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.5723 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.5676 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.5668 | Remote Similarity | NPD2457 | Phase 2 |
0.5668 | Remote Similarity | NPD2456 | Phase 2 |
0.5667 | Remote Similarity | NPD9582 | Phase 3 |
0.5654 | Remote Similarity | NPD5627 | Approved |
0.5652 | Remote Similarity | NPD534 | Phase 2 |
0.5652 | Remote Similarity | NPD537 | Phase 2 |
0.5628 | Remote Similarity | NPD1915 | Phase 1 |
0.5625 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.5613 | Remote Similarity | NPD4262 | Discontinued |
0.5612 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
PubChem CID   | 20279 |
ChEMBL   | CHEMBL1619 |
ZINC   |
Molecular Weight:   | 285.06 |
ALogP:   | -1.7568 |
MLogP:   | 1.57 |
XLogP:   | -0.692 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 119.31 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |